Section 203 - Submission, collection, and maintenance of data.

UT Code § 58-37f-203 (2019) (N/A)
Copy with citation
Copy as parenthetical citation

(1) (a) The division shall implement on a statewide basis, including non-resident pharmacies as defined in Section 58-17b-102, the following two options for a pharmacist to submit information: (i) real-time submission of the information required to be submitted under this part to the controlled substance database; and (ii) 24-hour daily or next business day, whichever is later, batch submission of the information required to be submitted under this part to the controlled substance database. (b) (i) On and after January 1, 2016, a pharmacist shall comply with either: (A) the submission time requirements established by the division under Subsection (1)(a)(i); or (B) the submission time requirements established by the division under Subsection (1)(a)(ii). (ii) Prior to January 1, 2016, a pharmacist may submit information using either option under this Subsection (1). (c) The division shall comply with Title 63G, Chapter 6a, Utah Procurement Code.

(a) The division shall implement on a statewide basis, including non-resident pharmacies as defined in Section 58-17b-102, the following two options for a pharmacist to submit information: (i) real-time submission of the information required to be submitted under this part to the controlled substance database; and (ii) 24-hour daily or next business day, whichever is later, batch submission of the information required to be submitted under this part to the controlled substance database.

(i) real-time submission of the information required to be submitted under this part to the controlled substance database; and

(ii) 24-hour daily or next business day, whichever is later, batch submission of the information required to be submitted under this part to the controlled substance database.

(b) (i) On and after January 1, 2016, a pharmacist shall comply with either: (A) the submission time requirements established by the division under Subsection (1)(a)(i); or (B) the submission time requirements established by the division under Subsection (1)(a)(ii). (ii) Prior to January 1, 2016, a pharmacist may submit information using either option under this Subsection (1).

(i) On and after January 1, 2016, a pharmacist shall comply with either: (A) the submission time requirements established by the division under Subsection (1)(a)(i); or (B) the submission time requirements established by the division under Subsection (1)(a)(ii).

(A) the submission time requirements established by the division under Subsection (1)(a)(i); or

(B) the submission time requirements established by the division under Subsection (1)(a)(ii).

(ii) Prior to January 1, 2016, a pharmacist may submit information using either option under this Subsection (1).

(c) The division shall comply with Title 63G, Chapter 6a, Utah Procurement Code.

(2) (a) The pharmacist-in-charge and the pharmacist of the drug outlet where a controlled substance is dispensed shall submit the data described in this section to the division in accordance with: (i) the requirements of this section; (ii) the procedures established by the division; (iii) additional types of information or data fields established by the division; and (iv) the format established by the division. (b) A dispensing medical practitioner licensed under Chapter 17b, Part 8, Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy, shall comply with the provisions of this section and the dispensing medical practitioner shall assume the duties of the pharmacist under this chapter.

(a) The pharmacist-in-charge and the pharmacist of the drug outlet where a controlled substance is dispensed shall submit the data described in this section to the division in accordance with: (i) the requirements of this section; (ii) the procedures established by the division; (iii) additional types of information or data fields established by the division; and (iv) the format established by the division.

(i) the requirements of this section;

(ii) the procedures established by the division;

(iii) additional types of information or data fields established by the division; and

(iv) the format established by the division.

(b) A dispensing medical practitioner licensed under Chapter 17b, Part 8, Dispensing Medical Practitioner and Dispensing Medical Practitioner Clinic Pharmacy, shall comply with the provisions of this section and the dispensing medical practitioner shall assume the duties of the pharmacist under this chapter.

(3) (a) The pharmacist-in-charge and the pharmacist described in Subsection (2)(b) shall, for each controlled substance dispensed by a pharmacist under the pharmacist's supervision other than those dispensed for an inpatient at a health care facility, submit to the division any type of information or data field established by the division by rule in accordance with Subsection (6) regarding: (i) each controlled substance that is dispensed by the pharmacist or under the pharmacist's supervision; and (ii) each noncontrolled substance that is: (A) designated by the division under Subsection (8)(a); and (B) dispensed by the pharmacist or under the pharmacist's supervision. (b) Subsection (3)(a) does not apply to a drug that is dispensed for an inpatient at a health care facility.

(a) The pharmacist-in-charge and the pharmacist described in Subsection (2)(b) shall, for each controlled substance dispensed by a pharmacist under the pharmacist's supervision other than those dispensed for an inpatient at a health care facility, submit to the division any type of information or data field established by the division by rule in accordance with Subsection (6) regarding: (i) each controlled substance that is dispensed by the pharmacist or under the pharmacist's supervision; and (ii) each noncontrolled substance that is: (A) designated by the division under Subsection (8)(a); and (B) dispensed by the pharmacist or under the pharmacist's supervision.

(i) each controlled substance that is dispensed by the pharmacist or under the pharmacist's supervision; and

(ii) each noncontrolled substance that is: (A) designated by the division under Subsection (8)(a); and (B) dispensed by the pharmacist or under the pharmacist's supervision.

(A) designated by the division under Subsection (8)(a); and

(B) dispensed by the pharmacist or under the pharmacist's supervision.

(b) Subsection (3)(a) does not apply to a drug that is dispensed for an inpatient at a health care facility.

(4) An individual whose records are in the database may obtain those records upon submission of a written request to the division.

(5) (a) A patient whose record is in the database may contact the division in writing to request correction of any of the patient's database information that is incorrect. The patient shall provide a postal address for the division's response. (b) The division shall grant or deny the request within 30 days from receipt of the request and shall advise the requesting patient of its decision by mail postmarked within 35 days of receipt of the request. (c) If the division denies a request under this Subsection (5) or does not respond within 35 days, the patient may submit an appeal to the Department of Commerce, within 60 days after the postmark date of the patient's letter making a request for a correction under this Subsection (5).

(a) A patient whose record is in the database may contact the division in writing to request correction of any of the patient's database information that is incorrect. The patient shall provide a postal address for the division's response.

(b) The division shall grant or deny the request within 30 days from receipt of the request and shall advise the requesting patient of its decision by mail postmarked within 35 days of receipt of the request.

(c) If the division denies a request under this Subsection (5) or does not respond within 35 days, the patient may submit an appeal to the Department of Commerce, within 60 days after the postmark date of the patient's letter making a request for a correction under this Subsection (5).

(6) The division shall make rules, in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act, to establish submission requirements under this part, including: (a) electronic format; (b) submission procedures; and (c) required information and data fields.

(a) electronic format;

(b) submission procedures; and

(c) required information and data fields.

(7) The division shall ensure that the database system records and maintains for reference: (a) the identification of each individual who requests or receives information from the database; (b) the information provided to each individual; and (c) the date and time that the information is requested or provided.

(a) the identification of each individual who requests or receives information from the database;

(b) the information provided to each individual; and

(c) the date and time that the information is requested or provided.

(8) (a) The division, in collaboration with the Utah Controlled Substance Advisory Committee created in Section 58-38a-201, shall designate a list of noncontrolled substances described in Subsection (8)(b) by rule made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act. (b) To determine whether a prescription drug should be designated in the schedules of controlled substances under this chapter, the division may collect information about a prescription drug as defined in Section 58-17b-102 that is not designated in the schedules of controlled substances under this chapter.

(a) The division, in collaboration with the Utah Controlled Substance Advisory Committee created in Section 58-38a-201, shall designate a list of noncontrolled substances described in Subsection (8)(b) by rule made in accordance with Title 63G, Chapter 3, Utah Administrative Rulemaking Act.

(b) To determine whether a prescription drug should be designated in the schedules of controlled substances under this chapter, the division may collect information about a prescription drug as defined in Section 58-17b-102 that is not designated in the schedules of controlled substances under this chapter.